✦ LIBER ✦

Assessing response to osteoporosis therapy

✍ Scribed by E. M. Lewiecki; N. B. Watts

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 115 KB
Volume: 19
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-008-0661-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of response to therapy using

Assessment of response to therapy using conventional imaging

✍ Sheila C. Rankin 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 351 KB

Bone turnover rate predicts the response

Bone turnover rate predicts the response to estrogen therapy in postmenopausal osteoporosis

✍ S. Gonnelli; D. Agnusdei; C. Cepollaro; R. Palmieri; P. Pondrelli; D. Borracelli 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 141 KB

Assessing response to therapy of spinal

Assessing response to therapy of spinal metastases with gadolinium-enhanced MR imaging

✍ Kazuro Sugimura; Akiko Kajitani; Hiromi Okizuka; Masaki Sugihara; Masami Mizutan 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

## Abstract The utility of gadolinium‐enhanced magnetic resonance (MR) imaging in assessing the response of spinal metastases to therapy was evaluated. Fifteen patients (62 affected vertebral bodies) with spinal metastases were evaluated with gadopentetate dimeglumineenhanced imaging before and aft

Vitamin D receptor genotypes and respons

Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis

✍ Zaher K. Otrock; Rami A. Mahfouz; Khalil M. Charafeddine; Roni F. Rayes; Laila F 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 53 KB

Predicting Subsequent Bone Density Respo

Predicting Subsequent Bone Density Response to Intermittent Cyclical Therapy with Etidronate from Initial Density Response in Patients with Osteoporosis

✍ R. G. Crilly; R. J. Sebaldt; A. B. Hodsman; J. D. Adachi; J. P. Brown; C. H. Gol 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 117 KB

Use of oesophagogastroscopy to assess th

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

✍ W. A. Brown; J. Thomas; D. Gotley; B. H. Burmeister; K.-H. Lim; I. Martin; E. T. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## Background Approximately 25 per cent of patients with oesophageal cancer who undergo neoadjuvant chemoradiotherapy have no evidence of tumour in the resected specimen (complete pathological response). Those who do not respond have a poor 5-year survival compared with complete respon